Adial Pharmaceuticals, Inc. (AZR): insider trading, Congress trades & who owns it

Insider signal
40/100
Insider selling · 90 days
Insider buys
$106K
1 buyer · 12 months
Insider sales
$0
0 sellers · 12 months
Funds holding
17
13F · Q2 2026
Congress trades
None
none in 2 years

Adial Pharmaceuticals, Inc. insiders have been one-way buyers this past year: one person put roughly $106,000 into the stock and nobody sold at market prices.

The largest purchase came from Coastlands Capital LP (10% Owner), about $65,000.

Quarter by quarter: 2 quarters in a row of net buying by insiders. Insiders bought in 2 of the last 7 full quarters. On the institutional side, 17 funds reported holding AZR at the end of Q2 2026, and more funds bought than sold.

Want the full picture on AZR? Price & valuation, financials by quarter, who owns it, dilution, earnings and a written bull & bear case. See what's inside ↓
See the full AZR report — free account

Latest insider trades in AZR

FiledInsiderRoleTypeSharesPriceValueSource
Jul 16, 2026Coastlands Capital LP10% OwnerBuy1,233$2.75$3KSEC
Jul 16, 2026Coastlands Capital LP10% OwnerBuy2,000$2.65$5KSEC
Jul 13, 2026Coastlands Capital LP10% OwnerBuy10,053$2.79$28KSEC
Jul 13, 2026Coastlands Capital LP10% OwnerBuy1,700$2.70$5KSEC
Jul 1, 2026Coastlands Capital LP10% OwnerBuy25,000$2.60$65KSEC
Oct 3, 2023Schuyler KevinDirectorBuy700$2.74$2KSEC
The full AZR report

This page shows the insider trades. The full AZR report shows everything around them.

Price and valuation, revenue and profit by quarter, who owns it, dilution, earnings timing and a written bull & bear case, in one report you can also print or save as a PDF. Here is what each section looks like (screenshots from a real report):

CapitalSnitch report section: Live price & key numbers
Live price & key numbersScout

Price, market cap, P/E, revenue and profit growth at a glance.

CapitalSnitch report section: Bull case vs bear case
Bull case vs bear caseAnalyst

A written read of everything below: what supports the stock, what worries.

CapitalSnitch report section: Insider signal score
Insider signal scoreFree

A 0-100 score with the reasons, plus earnings date, volatility and analyst ratings (Analyst).

CapitalSnitch report section: Revenue & profit by quarter
Revenue & profit by quarterScout

Three years of results from SEC filings, growth marked quarter by quarter.

CapitalSnitch report section: Insider buying vs selling by quarter
Insider buying vs selling by quarterScout

Streaks like “7 quarters of net selling” spotted for you.

CapitalSnitch report section: Who owns it (13F)
Who owns it (13F)Scout

Top funds, who added, who cut and who sold out last quarter.

CapitalSnitch report section: Congress trades
Congress tradesFree

Every House and Senate trade in the stock, late filers flagged.

CapitalSnitch report section: Dilution tracker
Dilution trackerAnalyst

Stock offerings, shelf registrations and share-count growth, scored.

CapitalSnitch report section: Snapshot for your trading style
Snapshot for your trading styleAnalyst

Day trading, swing trading and long-term numbers side by side.

Free plan: insider trades, insider signal and Congress trades. Sections marked Scout or Analyst unlock with that plan (from $29/month). Screenshots: Micron Technology report, Oct 19, 2026.

Questions about AZR

Are insiders buying or selling AZR stock?

In the last 12 months Adial Pharmaceuticals, Inc. insiders made open-market purchases worth about $106,000 and sales worth about $0. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.

When was the last insider trade in AZR?

The most recent open-market insider trade in AZR was filed on 2026-07-16.

How many institutions own AZR?

17 investment managers reported holding AZR in SEC Form 13F filings for Q2 2026.

Has any member of Congress traded AZR?

No congressional trades in AZR were reported in the past two years. The full list is free on CapitalSnitch.

Also active in insider buying

Free weekly email: the week's biggest insider buys and Congress trades, every Monday. No spam, one-click unsubscribe.

Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).